Search

Your search keyword '"Maleki I"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Maleki I" Remove constraint Author: "Maleki I"
95 results on '"Maleki I"'

Search Results

1. Concomitant pleural tuberculosis and aspiration pneumonia due to epiphrenic diverticula: a case report

2. Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Lymphocyte to Monocyte Ratio in Gastric Cancer Patients Compared with the Control Group and Its Association with Pathological Factors of the Disease.

3. New class of hybrid explicit methods for numerical solution of optimal control problems.

5. P742 Iranian Registry of Crohn’s and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol

6. A closed-form solution for the bending analysis of composite sandwich pipe with compliance core based on high-order sandwich theory.

9. An Analytical Study of the Effect of Fluid Flow on Damping Characteristics in Deep Drilling

10. Investigating the Effect of Fluid Flow on Chatter Vibration in Drilling

11. Urinary tract infection among intellectual disability individuals ?Etiology and antibiotic resistance patterns? in rehabilitation centers of Mazandaran province, Northern Iran

13. High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease.

14. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease

17. Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease

18. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease

20. Short term effects of ginger on quality of life, disease activity index, inflammatory and oxidative stress factors in ulcerative colitis

22. Polytelluride square planar chain-induced anharmonicity results in ultralow thermal conductivity and high thermoelectric efficiency in Al 2 Te 5 monolayers.

23. Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn's and Colitis (IRCC).

24. Beyond metals: theoretical discovery of semiconducting MAX phases and their potential application in thermoelectrics.

25. Causes of Colectomy in Patients with Ulcerative Colitis: Findings from an Iranian National Registry.

26. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).

27. Prevalence and risk factors of gastroesophageal reflux disease symptoms in Mazandaran, North of Iran: A Tabari cohort study.

28. Epidemiological, Endoscopic, Clinical, and Pathological Features of Patients with Celiac Diseases in Southern Littoral of Caspian Sea.

29. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East.

30. Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial.

31. Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication.

32. Face-to-face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population-based research.

33. Evaluation of Circulating Leptin and Its Receptor (Ob-R) Tissue Expression in Colorectal Cancer, a Report From North of Iran.

34. Role of BTLA/HVEM network in development of gastric cancer.

35. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.

36. Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households.

37. Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication.

38. Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications.

39. Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19.

40. Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.

41. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.

42. Invasion front dynamics in disordered environments.

43. A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol.

44. The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment.

45. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis.

46. Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis.

47. Evaluation of demographic, pathologic, and clinical characteristics and overall survival of patients with colon cancer in Northern Iran (Mazandaran Province) during 2012-2019.

48. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.

49. Helicobacter pylori eradication in the management of glaucoma.

50. Achieving an Ultrahigh Power Factor in Sb 2 Te 2 Se Monolayers via Valence Band Convergence.

Catalog

Books, media, physical & digital resources